14-24262228-G-T
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The ENST00000206765.11(TGM1):c.125C>A(p.Ser42Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00537 in 1,613,880 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S42S) has been classified as Likely benign.
Frequency
Consequence
ENST00000206765.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGM1 | NM_000359.3 | c.125C>A | p.Ser42Tyr | missense_variant | 2/15 | ENST00000206765.11 | NP_000350.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGM1 | ENST00000206765.11 | c.125C>A | p.Ser42Tyr | missense_variant | 2/15 | 1 | NM_000359.3 | ENSP00000206765 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00415 AC: 632AN: 152222Hom.: 7 Cov.: 32
GnomAD3 exomes AF: 0.00427 AC: 1072AN: 251102Hom.: 3 AF XY: 0.00411 AC XY: 558AN XY: 135872
GnomAD4 exome AF: 0.00550 AC: 8039AN: 1461540Hom.: 34 Cov.: 33 AF XY: 0.00529 AC XY: 3849AN XY: 727084
GnomAD4 genome AF: 0.00415 AC: 632AN: 152340Hom.: 7 Cov.: 32 AF XY: 0.00415 AC XY: 309AN XY: 74492
ClinVar
Submissions by phenotype
Autosomal recessive congenital ichthyosis 1 Pathogenic:1Uncertain:1Benign:1Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not provided, no classification provided | phenotyping only | GenomeConnect - Brain Gene Registry | - | Variant interpreted as Uncertain significance and reported on 01-16-2019 by Lab or GTR ID 1006. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR ) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator John Constantino MD PhD from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 27, 1995 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 02, 2020 | - - |
not specified Benign:3
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 20, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 02, 2024 | The p.Ser42Tyr variant in TGM1 is classified as likely benign because it has been identified in 1.3% (4/316) of Middle Eastern and 0.67% (71/10628) of European Finnish chromosomes by gnomAD (http://gnomad.broadinstitute.org, v.3.1.2), which is greater than the expected frequency of a pathogenic TGM1 variant causing disease. In addition, in vitro functional studies provide some evidence that this variant does not impact or increases protein expression (Candi 1998 PMID: 9593710, Numata 2016 PMID: 26990434). ACMG/AMP Criteria applied: BS1, BS3_Supporting. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | TGM1: BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at